v3.22.1
Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Income Statement [Abstract]    
Sales, net of returns and allowances $ 14,299 $ 521,060
Cost of sales 3,923,351 6,225,299
Gross loss (3,909,052) (5,704,239)
Operating expenses    
Selling, general and administrative 11,910,259 6,885,830
Research and development 4,011,934 3,863,715
Total operating expenses 15,922,193 10,749,545
Loss from operations (19,831,245) (16,453,784)
Interest expense (income), net 2,223,290 (14,920,473)
Other loss 0 (136,605,952)
Loss before benefit for income taxes (22,054,535) (138,139,263)
Benefit for income taxes 0 (17,632,492)
Net loss $ (22,054,535) $ (120,506,771)
Net loss per share of common stock    
Basic (in usd per share) $ (0.15) $ (0.98)
Diluted (in usd per share) $ (0.15) $ (1.04)
Weighted average shares used in computing net loss per share of common stock    
Basic (in shares) 151,939,491 122,633,856
Diluted (in shares) 151,939,491 128,301,184

Source